Location History:
- Salt Lake City, UT (US) (2011 - 2019)
- Potomac Maryland, MD (US) (2022)
- Potomac, MD (US) (2020 - 2024)
Company Filing History:
5 out of 2,078 
1 out of 1,647 
Years Active: 2011-2024
Title: Brian D Klein: Innovator in Metabotropic Glutamatergic Receptor Research
Introduction
Brian D Klein is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of pharmacology, particularly in the area of metabotropic glutamatergic receptors. With a total of six patents to his name, Klein's work has the potential to impact therapeutic approaches for various neurological conditions.
Latest Patents
Klein's latest patents focus on combinations that include positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2. These inventions relate to the use of a positive allosteric modulator ('PAM') of metabotropic glutamatergic receptor subtype 2 (“mGluR2”) or a pharmaceutically acceptable salt or solvate thereof. Additionally, they encompass orthosteric agonists of metabotropic glutamatergic receptor subtype 2 compounds, along with synaptic vesicle protein 2A (“SV2A”) ligands.
Career Highlights
Throughout his career, Klein has worked with prominent organizations such as Janssen Pharmaceutica and the University of Utah Research Foundation. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.
Collaborations
Klein has collaborated with notable colleagues, including Hilde Lavreysen and Stefan Maria Christiaan Pype. These partnerships have further enriched his research endeavors and expanded the scope of his inventions.
Conclusion
Brian D Klein is a distinguished inventor whose work in metabotropic glutamatergic receptor research has led to significant advancements in pharmacology. His contributions continue to shape the future of therapeutic interventions in neurology.